| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fertilization in Vitro | 56 | 2022 | 1240 | 5.140 |
Why?
|
| Embryo Transfer | 24 | 2022 | 502 | 4.940 |
Why?
|
| Cryopreservation | 23 | 2021 | 630 | 4.440 |
Why?
|
| Infertility | 20 | 2022 | 573 | 4.060 |
Why?
|
| Oocytes | 25 | 2022 | 1217 | 2.750 |
Why?
|
| Cryoprotective Agents | 8 | 2020 | 91 | 1.810 |
Why?
|
| Pregnancy Rate | 22 | 2022 | 599 | 1.760 |
Why?
|
| Live Birth | 12 | 2022 | 459 | 1.570 |
Why?
|
| Embryo Implantation | 9 | 2018 | 257 | 1.510 |
Why?
|
| Pregnancy Outcome | 19 | 2020 | 2695 | 1.430 |
Why?
|
| Trehalose | 7 | 2016 | 93 | 1.350 |
Why?
|
| Ovarian Follicle | 6 | 2016 | 234 | 1.330 |
Why?
|
| Blastocyst | 5 | 2020 | 432 | 1.180 |
Why?
|
| Infertility, Female | 10 | 2017 | 756 | 1.160 |
Why?
|
| Ovarian Hyperstimulation Syndrome | 5 | 2012 | 51 | 1.110 |
Why?
|
| Oocyte Retrieval | 7 | 2020 | 153 | 1.060 |
Why?
|
| Reproductive Techniques, Assisted | 10 | 2022 | 454 | 1.060 |
Why?
|
| Birth Rate | 3 | 2022 | 146 | 1.050 |
Why?
|
| Fertility | 9 | 2018 | 717 | 1.020 |
Why?
|
| Ovulation Induction | 8 | 2015 | 251 | 0.930 |
Why?
|
| Pregnancy | 59 | 2022 | 27180 | 0.870 |
Why?
|
| Sperm Motility | 6 | 2017 | 254 | 0.840 |
Why?
|
| Premature Birth | 3 | 2022 | 1529 | 0.810 |
Why?
|
| Fetal Resorption | 1 | 2020 | 17 | 0.810 |
Why?
|
| Infertility, Male | 8 | 2021 | 408 | 0.800 |
Why?
|
| Reproductive Medicine | 1 | 2022 | 100 | 0.790 |
Why?
|
| Spermatozoa | 8 | 2016 | 640 | 0.760 |
Why?
|
| Radiation Dosage | 17 | 2017 | 2038 | 0.730 |
Why?
|
| Abortion, Spontaneous | 3 | 2020 | 467 | 0.710 |
Why?
|
| Peromyscus | 1 | 2016 | 16 | 0.620 |
Why?
|
| Semen Preservation | 1 | 2016 | 35 | 0.610 |
Why?
|
| Embryonic Development | 5 | 2013 | 711 | 0.570 |
Why?
|
| Estradiol | 8 | 2015 | 1984 | 0.540 |
Why?
|
| Fertilization | 6 | 2021 | 191 | 0.520 |
Why?
|
| Syringes | 1 | 2013 | 45 | 0.500 |
Why?
|
| Thinness | 1 | 2017 | 484 | 0.500 |
Why?
|
| Paternal Exposure | 4 | 2017 | 90 | 0.480 |
Why?
|
| Anti-Mullerian Hormone | 1 | 2015 | 386 | 0.480 |
Why?
|
| Tomography, X-Ray Computed | 17 | 2017 | 20398 | 0.460 |
Why?
|
| Pregnancy, Ectopic | 1 | 2013 | 137 | 0.460 |
Why?
|
| Placenta | 4 | 2022 | 1533 | 0.460 |
Why?
|
| Radiography, Abdominal | 8 | 2010 | 580 | 0.440 |
Why?
|
| Sucrose | 3 | 2016 | 186 | 0.430 |
Why?
|
| Radiometry | 7 | 2008 | 817 | 0.430 |
Why?
|
| Ovary | 5 | 2010 | 1003 | 0.420 |
Why?
|
| Chorionic Gonadotropin | 2 | 2012 | 458 | 0.410 |
Why?
|
| Microinjections | 5 | 2005 | 369 | 0.400 |
Why?
|
| Placenta Diseases | 3 | 2022 | 188 | 0.390 |
Why?
|
| Sperm Count | 7 | 2017 | 226 | 0.390 |
Why?
|
| Sperm Injections, Intracytoplasmic | 4 | 2018 | 147 | 0.390 |
Why?
|
| Dimethyl Sulfoxide | 2 | 2008 | 254 | 0.370 |
Why?
|
| Cell Culture Techniques | 2 | 2018 | 1724 | 0.360 |
Why?
|
| Soy Foods | 3 | 2015 | 49 | 0.360 |
Why?
|
| Adult | 78 | 2021 | 212129 | 0.360 |
Why?
|
| Female | 97 | 2022 | 377334 | 0.350 |
Why?
|
| Birth Weight | 4 | 2022 | 1927 | 0.350 |
Why?
|
| Body Mass Index | 9 | 2017 | 12488 | 0.350 |
Why?
|
| Professional Practice | 1 | 2010 | 331 | 0.350 |
Why?
|
| Follicle Stimulating Hormone | 5 | 2007 | 730 | 0.340 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2010 | 266 | 0.340 |
Why?
|
| Caffeine | 3 | 2017 | 700 | 0.330 |
Why?
|
| Twinning, Monozygotic | 1 | 2007 | 17 | 0.330 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2008 | 1229 | 0.330 |
Why?
|
| Retrospective Studies | 29 | 2022 | 72255 | 0.330 |
Why?
|
| Embryo, Mammalian | 6 | 2019 | 1764 | 0.320 |
Why?
|
| Pre-Eclampsia | 2 | 2012 | 1108 | 0.310 |
Why?
|
| Flame Retardants | 2 | 2017 | 78 | 0.310 |
Why?
|
| Environmental Pollutants | 4 | 2017 | 1038 | 0.300 |
Why?
|
| Twins | 2 | 2011 | 358 | 0.300 |
Why?
|
| Tomography, Spiral Computed | 6 | 2005 | 293 | 0.300 |
Why?
|
| Logistic Models | 8 | 2020 | 13594 | 0.300 |
Why?
|
| Zygote | 3 | 2003 | 126 | 0.290 |
Why?
|
| Semen | 6 | 2012 | 282 | 0.290 |
Why?
|
| Tomography Scanners, X-Ray Computed | 3 | 2004 | 182 | 0.280 |
Why?
|
| Humans | 113 | 2022 | 715124 | 0.280 |
Why?
|
| Telemedicine | 1 | 2022 | 2612 | 0.270 |
Why?
|
| Prophase | 2 | 1994 | 21 | 0.270 |
Why?
|
| Stress, Psychological | 1 | 2020 | 4168 | 0.260 |
Why?
|
| Parabens | 2 | 2015 | 108 | 0.260 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2008 | 412 | 0.260 |
Why?
|
| Pandemics | 2 | 2022 | 7213 | 0.250 |
Why?
|
| Polyploidy | 3 | 1998 | 123 | 0.250 |
Why?
|
| Phantoms, Imaging | 9 | 2012 | 2412 | 0.240 |
Why?
|
| Treatment Outcome | 20 | 2021 | 62186 | 0.240 |
Why?
|
| Attitude to Health | 1 | 2012 | 2100 | 0.230 |
Why?
|
| Semen Analysis | 7 | 2017 | 226 | 0.230 |
Why?
|
| Birth Intervals | 1 | 2022 | 54 | 0.230 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 445 | 0.220 |
Why?
|
| Pelvis | 4 | 2010 | 693 | 0.220 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2016 | 384 | 0.220 |
Why?
|
| Gonadotropins | 4 | 2015 | 237 | 0.220 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 3158 | 0.220 |
Why?
|
| Radiation Protection | 5 | 2009 | 456 | 0.210 |
Why?
|
| Healthcare Disparities | 1 | 2017 | 3027 | 0.210 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 3276 | 0.210 |
Why?
|
| Carbohydrate Metabolism | 1 | 2002 | 282 | 0.210 |
Why?
|
| Infant, Newborn | 8 | 2022 | 24645 | 0.210 |
Why?
|
| Menopause | 2 | 2008 | 1534 | 0.210 |
Why?
|
| Freezing | 2 | 2016 | 297 | 0.210 |
Why?
|
| Eating | 3 | 2018 | 1471 | 0.210 |
Why?
|
| Cell Survival | 6 | 2005 | 6131 | 0.210 |
Why?
|
| Fallopian Tubes | 2 | 2011 | 175 | 0.210 |
Why?
|
| Body Burden | 4 | 2009 | 166 | 0.200 |
Why?
|
| Vitrification | 1 | 2020 | 42 | 0.200 |
Why?
|
| Odds Ratio | 4 | 2018 | 9968 | 0.200 |
Why?
|
| Cytoskeleton | 3 | 2004 | 1222 | 0.190 |
Why?
|
| Chi-Square Distribution | 2 | 2017 | 3565 | 0.190 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2012 | 433 | 0.190 |
Why?
|
| Multivariate Analysis | 4 | 2018 | 12477 | 0.190 |
Why?
|
| Radiation Injuries | 4 | 2009 | 1226 | 0.190 |
Why?
|
| Prospective Studies | 22 | 2022 | 51181 | 0.180 |
Why?
|
| Cumulus Cells | 1 | 2018 | 18 | 0.180 |
Why?
|
| Radiographic Image Enhancement | 5 | 2008 | 921 | 0.180 |
Why?
|
| Oligosaccharides | 2 | 2016 | 402 | 0.180 |
Why?
|
| Phenols | 2 | 2015 | 500 | 0.180 |
Why?
|
| Lasers | 2 | 2008 | 955 | 0.170 |
Why?
|
| Cells, Immobilized | 1 | 2018 | 36 | 0.170 |
Why?
|
| Obesity | 4 | 2017 | 12192 | 0.170 |
Why?
|
| Ovarian Cysts | 1 | 1999 | 114 | 0.170 |
Why?
|
| Folic Acid | 2 | 2015 | 1245 | 0.170 |
Why?
|
| Academic Medical Centers | 4 | 2018 | 2787 | 0.170 |
Why?
|
| Body Size | 3 | 2010 | 466 | 0.170 |
Why?
|
| Insurance Coverage | 1 | 2009 | 1863 | 0.170 |
Why?
|
| Estrogens, Non-Steroidal | 1 | 1997 | 47 | 0.160 |
Why?
|
| Diethylstilbestrol | 1 | 1997 | 92 | 0.160 |
Why?
|
| Lab-On-A-Chip Devices | 2 | 2018 | 388 | 0.160 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 845 | 0.160 |
Why?
|
| Embryo Culture Techniques | 1 | 2017 | 78 | 0.160 |
Why?
|
| Placenta Accreta | 1 | 2020 | 185 | 0.160 |
Why?
|
| Preimplantation Diagnosis | 1 | 2019 | 129 | 0.160 |
Why?
|
| Risk Factors | 13 | 2020 | 70704 | 0.160 |
Why?
|
| Pesticide Residues | 1 | 2018 | 88 | 0.160 |
Why?
|
| 3-O-Methylglucose | 1 | 2016 | 37 | 0.160 |
Why?
|
| Raffinose | 1 | 2016 | 48 | 0.150 |
Why?
|
| Radiation Monitoring | 1 | 2017 | 99 | 0.150 |
Why?
|
| Health Care Costs | 1 | 2009 | 3171 | 0.140 |
Why?
|
| Biotechnology | 1 | 2018 | 279 | 0.140 |
Why?
|
| Aneuploidy | 1 | 2019 | 476 | 0.140 |
Why?
|
| Ovulation | 1 | 2016 | 182 | 0.140 |
Why?
|
| Radiography, Thoracic | 4 | 2005 | 1344 | 0.140 |
Why?
|
| Learning Curve | 1 | 2017 | 203 | 0.140 |
Why?
|
| Osmolar Concentration | 3 | 2010 | 701 | 0.140 |
Why?
|
| Preconception Care | 1 | 2016 | 128 | 0.140 |
Why?
|
| Genetic Counseling | 1 | 2019 | 582 | 0.140 |
Why?
|
| Fetal Mortality | 1 | 2014 | 20 | 0.140 |
Why?
|
| Biomimetics | 1 | 2016 | 167 | 0.140 |
Why?
|
| Functional Food | 1 | 2014 | 20 | 0.130 |
Why?
|
| Fishes | 2 | 2015 | 549 | 0.130 |
Why?
|
| Seafood | 2 | 2015 | 372 | 0.130 |
Why?
|
| Leuprolide | 1 | 1996 | 308 | 0.130 |
Why?
|
| X-Rays | 2 | 2008 | 295 | 0.130 |
Why?
|
| Alcohol Drinking | 2 | 2017 | 3884 | 0.130 |
Why?
|
| Inhibins | 3 | 2000 | 227 | 0.130 |
Why?
|
| Meat Products | 1 | 2014 | 96 | 0.130 |
Why?
|
| Gestational Age | 2 | 2020 | 3414 | 0.130 |
Why?
|
| Male | 48 | 2021 | 351081 | 0.130 |
Why?
|
| Tissue Preservation | 1 | 1994 | 178 | 0.120 |
Why?
|
| Time Factors | 6 | 2018 | 41081 | 0.120 |
Why?
|
| Endometriosis | 2 | 1998 | 786 | 0.120 |
Why?
|
| Mercury | 1 | 2015 | 238 | 0.120 |
Why?
|
| Phthalic Acids | 1 | 2017 | 404 | 0.120 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2008 | 3950 | 0.120 |
Why?
|
| Glucose | 3 | 2016 | 4291 | 0.120 |
Why?
|
| Suction | 1 | 2013 | 262 | 0.110 |
Why?
|
| Isoflavones | 2 | 2015 | 144 | 0.110 |
Why?
|
| Vitamin B 12 | 1 | 2015 | 509 | 0.110 |
Why?
|
| Microfluidics | 1 | 2018 | 618 | 0.110 |
Why?
|
| Vegetables | 1 | 2018 | 1127 | 0.110 |
Why?
|
| Fruit | 1 | 2018 | 1109 | 0.110 |
Why?
|
| Meat | 1 | 2015 | 594 | 0.110 |
Why?
|
| Cohort Studies | 12 | 2017 | 39804 | 0.110 |
Why?
|
| Hair | 1 | 2015 | 445 | 0.110 |
Why?
|
| Animals | 18 | 2020 | 170726 | 0.100 |
Why?
|
| Diagnostic Techniques, Obstetrical and Gynecological | 1 | 2010 | 31 | 0.100 |
Why?
|
| Posthumous Conception | 1 | 2010 | 10 | 0.100 |
Why?
|
| Artifacts | 8 | 2012 | 1906 | 0.100 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 913 | 0.100 |
Why?
|
| Mice, Inbred DBA | 3 | 2008 | 680 | 0.100 |
Why?
|
| Gonadotropin-Releasing Hormone | 2 | 1996 | 1189 | 0.100 |
Why?
|
| Maternal Exposure | 1 | 2017 | 906 | 0.100 |
Why?
|
| Third-Party Consent | 1 | 2010 | 60 | 0.100 |
Why?
|
| Equipment Design | 5 | 2018 | 3628 | 0.100 |
Why?
|
| Cross-Sectional Studies | 4 | 2020 | 23283 | 0.100 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2012 | 8998 | 0.100 |
Why?
|
| Phase Transition | 1 | 2009 | 67 | 0.100 |
Why?
|
| Iohexol | 1 | 2010 | 202 | 0.090 |
Why?
|
| Hypoxia, Brain | 1 | 2010 | 136 | 0.090 |
Why?
|
| Propylene Glycols | 1 | 2009 | 96 | 0.090 |
Why?
|
| Trans Fatty Acids | 1 | 2010 | 152 | 0.090 |
Why?
|
| Prolactinoma | 1 | 2010 | 107 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2016 | 4010 | 0.090 |
Why?
|
| Granulosa Cells | 2 | 2000 | 124 | 0.090 |
Why?
|
| Health Care Surveys | 1 | 2017 | 2509 | 0.090 |
Why?
|
| Hyperprolactinemia | 1 | 2010 | 133 | 0.090 |
Why?
|
| Calorimetry, Differential Scanning | 1 | 2008 | 91 | 0.090 |
Why?
|
| Linear Models | 6 | 2017 | 5980 | 0.090 |
Why?
|
| Mice | 13 | 2020 | 80995 | 0.090 |
Why?
|
| DNA Fragmentation | 1 | 2009 | 249 | 0.090 |
Why?
|
| Gravidity | 1 | 2008 | 52 | 0.090 |
Why?
|
| Nitrogen | 1 | 2009 | 343 | 0.090 |
Why?
|
| Middle Aged | 26 | 2021 | 214871 | 0.080 |
Why?
|
| Uterus | 1 | 1992 | 669 | 0.080 |
Why?
|
| Endocrine Disruptors | 1 | 2010 | 198 | 0.080 |
Why?
|
| Crosses, Genetic | 1 | 2008 | 841 | 0.080 |
Why?
|
| Mice, Inbred Strains | 1 | 2009 | 1917 | 0.080 |
Why?
|
| Estrogens | 2 | 2012 | 1522 | 0.080 |
Why?
|
| Metaphase | 3 | 1998 | 165 | 0.080 |
Why?
|
| Cell Count | 1 | 2010 | 1920 | 0.070 |
Why?
|
| Scattering, Radiation | 1 | 2008 | 524 | 0.070 |
Why?
|
| Overweight | 2 | 2014 | 2237 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2019 | 3319 | 0.070 |
Why?
|
| Glycoproteins | 4 | 2000 | 2313 | 0.070 |
Why?
|
| Anxiety | 1 | 2020 | 3898 | 0.070 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 2827 | 0.070 |
Why?
|
| Immobilization | 1 | 2007 | 250 | 0.070 |
Why?
|
| Growth Substances | 2 | 1998 | 815 | 0.070 |
Why?
|
| Massachusetts | 4 | 2021 | 8734 | 0.070 |
Why?
|
| Hormones | 2 | 2000 | 858 | 0.070 |
Why?
|
| Noise | 1 | 2007 | 263 | 0.070 |
Why?
|
| Electrochemistry | 1 | 2005 | 157 | 0.070 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 1997 | 2316 | 0.070 |
Why?
|
| Fever | 1 | 2012 | 1589 | 0.070 |
Why?
|
| Microfluidic Analytical Techniques | 1 | 2011 | 776 | 0.070 |
Why?
|
| Parity | 1 | 2008 | 893 | 0.070 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2009 | 687 | 0.070 |
Why?
|
| Decision Making | 1 | 2019 | 3828 | 0.070 |
Why?
|
| Risk | 1 | 2017 | 9772 | 0.060 |
Why?
|
| Technology, Radiologic | 1 | 2004 | 174 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2202 | 0.060 |
Why?
|
| Predictive Value of Tests | 3 | 2015 | 15258 | 0.060 |
Why?
|
| Intracellular Membranes | 1 | 2005 | 413 | 0.060 |
Why?
|
| Chorionic Villi | 1 | 2003 | 50 | 0.060 |
Why?
|
| HEPES | 1 | 2003 | 11 | 0.060 |
Why?
|
| Family Characteristics | 2 | 2021 | 928 | 0.060 |
Why?
|
| Young Adult | 9 | 2021 | 56155 | 0.060 |
Why?
|
| Uterine Hemorrhage | 2 | 1997 | 243 | 0.060 |
Why?
|
| Tromethamine | 1 | 2003 | 31 | 0.060 |
Why?
|
| Dietary Fats | 1 | 2012 | 2049 | 0.060 |
Why?
|
| Posture | 1 | 2008 | 990 | 0.060 |
Why?
|
| Ovulation Detection | 1 | 2002 | 5 | 0.060 |
Why?
|
| Osmosis | 1 | 2002 | 115 | 0.060 |
Why?
|
| Sperm Immobilizing Agents | 1 | 2002 | 2 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2010 | 6531 | 0.060 |
Why?
|
| Zona Pellucida | 1 | 2002 | 18 | 0.060 |
Why?
|
| Follicular Fluid | 2 | 2000 | 79 | 0.060 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3194 | 0.060 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 213 | 0.060 |
Why?
|
| Liver Diseases | 1 | 2010 | 1254 | 0.060 |
Why?
|
| Dietary Supplements | 1 | 2014 | 3078 | 0.050 |
Why?
|
| Men | 1 | 2021 | 60 | 0.050 |
Why?
|
| Chromatography, Gas | 2 | 2012 | 168 | 0.050 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 1288 | 0.050 |
Why?
|
| Nutrition Assessment | 2 | 2015 | 728 | 0.050 |
Why?
|
| Receptors, Growth Factor | 2 | 2000 | 339 | 0.050 |
Why?
|
| Prostatic Secretory Proteins | 1 | 2000 | 25 | 0.050 |
Why?
|
| Pregnancy, Multiple | 1 | 2022 | 218 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2017 | 4646 | 0.050 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2005 | 1637 | 0.050 |
Why?
|
| Weight Loss | 1 | 2012 | 2487 | 0.050 |
Why?
|
| Depression | 1 | 2020 | 7256 | 0.050 |
Why?
|
| Carbohydrates | 1 | 2002 | 358 | 0.050 |
Why?
|
| Boston | 4 | 2017 | 9400 | 0.050 |
Why?
|
| Unnecessary Procedures | 1 | 2004 | 442 | 0.050 |
Why?
|
| Adolescent | 10 | 2018 | 84999 | 0.050 |
Why?
|
| DNA Damage | 1 | 2010 | 2467 | 0.050 |
Why?
|
| Models, Statistical | 2 | 2008 | 5028 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2008 | 22936 | 0.050 |
Why?
|
| Radiography | 3 | 2010 | 6994 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2004 | 563 | 0.050 |
Why?
|
| Placenta Previa | 1 | 2020 | 96 | 0.050 |
Why?
|
| Nafarelin | 1 | 1998 | 27 | 0.050 |
Why?
|
| Microscopy, Interference | 1 | 1998 | 35 | 0.040 |
Why?
|
| Receptors, LHRH | 1 | 1999 | 160 | 0.040 |
Why?
|
| Body Weight | 4 | 2012 | 4692 | 0.040 |
Why?
|
| Povidone | 1 | 1998 | 34 | 0.040 |
Why?
|
| Radioimmunoassay | 2 | 1996 | 956 | 0.040 |
Why?
|
| Confidence Intervals | 2 | 2014 | 2973 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2011 | 3687 | 0.040 |
Why?
|
| Reference Standards | 1 | 2002 | 997 | 0.040 |
Why?
|
| Menotropins | 1 | 1998 | 47 | 0.040 |
Why?
|
| Pilot Projects | 4 | 2010 | 8042 | 0.040 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1998 | 347 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2013 | 7836 | 0.040 |
Why?
|
| Medical History Taking | 1 | 2002 | 801 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2009 | 2333 | 0.040 |
Why?
|
| Optical Devices | 1 | 2018 | 37 | 0.040 |
Why?
|
| Electrophoresis | 1 | 2018 | 248 | 0.040 |
Why?
|
| Oils | 1 | 2018 | 66 | 0.040 |
Why?
|
| Emulsions | 1 | 2018 | 144 | 0.040 |
Why?
|
| Chromosomes | 2 | 1998 | 616 | 0.040 |
Why?
|
| Temperature | 1 | 2004 | 2158 | 0.040 |
Why?
|
| United States | 3 | 2017 | 67665 | 0.040 |
Why?
|
| Cell Aggregation | 1 | 2018 | 257 | 0.040 |
Why?
|
| Capsules | 1 | 2018 | 202 | 0.040 |
Why?
|
| Follistatin | 4 | 2000 | 139 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2005 | 1343 | 0.040 |
Why?
|
| Tissue Fixation | 1 | 1998 | 257 | 0.040 |
Why?
|
| Urinalysis | 2 | 2015 | 363 | 0.040 |
Why?
|
| Contrast Media | 1 | 2010 | 5270 | 0.040 |
Why?
|
| Seasons | 1 | 2003 | 1427 | 0.040 |
Why?
|
| Paracrine Communication | 1 | 1998 | 284 | 0.040 |
Why?
|
| Reference Values | 2 | 2014 | 5061 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2009 | 5258 | 0.040 |
Why?
|
| Silicon Dioxide | 1 | 1998 | 257 | 0.040 |
Why?
|
| Hysteroscopy | 1 | 1997 | 89 | 0.040 |
Why?
|
| Head | 1 | 2002 | 847 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2014 | 11285 | 0.040 |
Why?
|
| Teriparatide | 1 | 1998 | 231 | 0.040 |
Why?
|
| Uterine Cervical Neoplasms | 2 | 1998 | 1972 | 0.040 |
Why?
|
| Depressive Disorder, Major | 1 | 2013 | 4465 | 0.040 |
Why?
|
| Uterine Diseases | 1 | 1997 | 132 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19499 | 0.040 |
Why?
|
| Physical Examination | 1 | 2002 | 1243 | 0.040 |
Why?
|
| Follicular Phase | 1 | 1996 | 154 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2008 | 3563 | 0.040 |
Why?
|
| Clinical Protocols | 1 | 2002 | 1472 | 0.040 |
Why?
|
| Relative Biological Effectiveness | 2 | 2008 | 343 | 0.040 |
Why?
|
| Pectinidae | 1 | 2015 | 4 | 0.040 |
Why?
|
| Menstrual Cycle | 2 | 1996 | 531 | 0.040 |
Why?
|
| Poultry | 1 | 2015 | 83 | 0.040 |
Why?
|
| Aged | 16 | 2010 | 162674 | 0.040 |
Why?
|
| Software | 2 | 2008 | 4350 | 0.030 |
Why?
|
| Food Handling | 1 | 2015 | 136 | 0.030 |
Why?
|
| Endocrine Glands | 1 | 1995 | 100 | 0.030 |
Why?
|
| Carbonated Beverages | 1 | 2016 | 207 | 0.030 |
Why?
|
| Tea | 1 | 2016 | 257 | 0.030 |
Why?
|
| Shellfish | 1 | 2014 | 37 | 0.030 |
Why?
|
| Hysterectomy | 2 | 1998 | 904 | 0.030 |
Why?
|
| Regression Analysis | 2 | 2008 | 6480 | 0.030 |
Why?
|
| Diet Records | 1 | 2016 | 427 | 0.030 |
Why?
|
| Endometrium | 1 | 1997 | 404 | 0.030 |
Why?
|
| Polycystic Ovary Syndrome | 1 | 1997 | 331 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2003 | 2158 | 0.030 |
Why?
|
| Hydatidiform Mole | 1 | 1996 | 273 | 0.030 |
Why?
|
| Pediatrics | 1 | 2009 | 3553 | 0.030 |
Why?
|
| Random Allocation | 2 | 2011 | 2461 | 0.030 |
Why?
|
| Endosonography | 1 | 1997 | 575 | 0.030 |
Why?
|
| Spermatogenesis | 1 | 2014 | 260 | 0.030 |
Why?
|
| Prognosis | 2 | 2010 | 29168 | 0.030 |
Why?
|
| Gamete Intrafallopian Transfer | 1 | 1992 | 27 | 0.030 |
Why?
|
| Reproductive Control Agents | 1 | 2012 | 7 | 0.030 |
Why?
|
| Diet | 3 | 2016 | 7582 | 0.030 |
Why?
|
| Steroids | 1 | 1997 | 886 | 0.030 |
Why?
|
| Aged, 80 and over | 9 | 2010 | 58505 | 0.030 |
Why?
|
| Statistics as Topic | 2 | 2010 | 2406 | 0.030 |
Why?
|
| Endpoint Determination | 1 | 2015 | 621 | 0.030 |
Why?
|
| Coffee | 1 | 2016 | 553 | 0.030 |
Why?
|
| Microtubules | 1 | 1998 | 1207 | 0.030 |
Why?
|
| Hospitals, General | 1 | 2015 | 715 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2020 | 1322 | 0.030 |
Why?
|
| Water | 1 | 2018 | 1335 | 0.030 |
Why?
|
| Cells, Cultured | 3 | 2018 | 20101 | 0.030 |
Why?
|
| Risk Assessment | 5 | 2014 | 23511 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2015 | 1175 | 0.030 |
Why?
|
| Beverages | 1 | 2016 | 769 | 0.030 |
Why?
|
| Environmental Monitoring | 1 | 2017 | 1374 | 0.030 |
Why?
|
| Oligospermia | 1 | 2010 | 59 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1998 | 2815 | 0.030 |
Why?
|
| Ethics Committees, Clinical | 1 | 2010 | 54 | 0.020 |
Why?
|
| Age Factors | 2 | 2014 | 18789 | 0.020 |
Why?
|
| Heart | 1 | 2004 | 4326 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1994 | 2866 | 0.020 |
Why?
|
| Occupational Exposure | 1 | 2000 | 1775 | 0.020 |
Why?
|
| Activin Receptors | 2 | 2000 | 47 | 0.020 |
Why?
|
| Drug Administration Schedule | 2 | 2014 | 5039 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 13669 | 0.020 |
Why?
|
| Infant | 2 | 2021 | 34497 | 0.020 |
Why?
|
| Neoplasms | 1 | 1998 | 20515 | 0.020 |
Why?
|
| Insemination, Artificial | 1 | 2010 | 90 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1992 | 1742 | 0.020 |
Why?
|
| Reproductive Health Services | 1 | 2010 | 80 | 0.020 |
Why?
|
| Cell Size | 1 | 2011 | 660 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 986 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2021 | 41181 | 0.020 |
Why?
|
| Osteoporosis | 1 | 1998 | 1562 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2021 | 3396 | 0.020 |
Why?
|
| Child | 4 | 2021 | 74146 | 0.020 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2010 | 407 | 0.020 |
Why?
|
| Observer Variation | 2 | 2005 | 2680 | 0.020 |
Why?
|
| Activins | 2 | 2000 | 228 | 0.020 |
Why?
|
| Intracranial Hypertension | 1 | 2010 | 182 | 0.020 |
Why?
|
| Prolactin | 1 | 2010 | 674 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39285 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2001 | 5943 | 0.020 |
Why?
|
| Secondary Prevention | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2011 | 1372 | 0.020 |
Why?
|
| Biopsy | 1 | 2019 | 6750 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2011 | 695 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2000 | 13292 | 0.020 |
Why?
|
| Sex Hormone-Binding Globulin | 1 | 2009 | 542 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1998 | 2529 | 0.020 |
Why?
|
| Withholding Treatment | 1 | 2010 | 585 | 0.020 |
Why?
|
| Bone Density | 1 | 1998 | 3411 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 8016 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2010 | 34394 | 0.020 |
Why?
|
| Benzhydryl Compounds | 1 | 2010 | 705 | 0.020 |
Why?
|
| Prevalence | 2 | 2012 | 14869 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2012 | 1748 | 0.020 |
Why?
|
| Aging | 1 | 2003 | 8368 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1998 | 4028 | 0.010 |
Why?
|
| Abdominal Neoplasms | 1 | 2004 | 299 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2009 | 888 | 0.010 |
Why?
|
| Pelvic Neoplasms | 1 | 2004 | 251 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1901 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2013 | 2836 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2011 | 3912 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 7480 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2010 | 4916 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21790 | 0.010 |
Why?
|
| Heart Arrest | 1 | 2010 | 1374 | 0.010 |
Why?
|
| New England | 1 | 2003 | 1018 | 0.010 |
Why?
|
| Acetabulum | 1 | 2004 | 501 | 0.010 |
Why?
|
| Metals | 1 | 2005 | 691 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1998 | 6371 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2004 | 14877 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 8912 | 0.010 |
Why?
|
| Incidental Findings | 1 | 2004 | 667 | 0.010 |
Why?
|
| Comorbidity | 1 | 2013 | 10423 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 2005 | 910 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2003 | 2611 | 0.010 |
Why?
|
| Liver | 2 | 2004 | 7647 | 0.010 |
Why?
|
| Abdomen | 1 | 2004 | 1101 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 2936 | 0.010 |
Why?
|
| Colloids | 1 | 1998 | 145 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2012 | 6075 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2014 | 13573 | 0.010 |
Why?
|
| Sex Factors | 1 | 2012 | 10651 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2395 | 0.010 |
Why?
|
| Life Style | 1 | 2009 | 3708 | 0.010 |
Why?
|
| Blood Chemical Analysis | 1 | 1998 | 462 | 0.010 |
Why?
|
| Progesterone | 1 | 2000 | 737 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 1997 | 604 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2014 | 16011 | 0.010 |
Why?
|
| Environmental Exposure | 1 | 2010 | 4046 | 0.010 |
Why?
|
| Thoracic Neoplasms | 1 | 1997 | 264 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 1998 | 591 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1998 | 12567 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 1997 | 1988 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 1998 | 800 | 0.010 |
Why?
|
| Actins | 1 | 2000 | 2187 | 0.010 |
Why?
|
| Image Enhancement | 1 | 2004 | 2978 | 0.010 |
Why?
|
| Progestins | 1 | 1993 | 287 | 0.010 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1679 | 0.010 |
Why?
|
| Cytoplasm | 1 | 1996 | 1636 | 0.010 |
Why?
|
| Feedback | 1 | 1995 | 755 | 0.010 |
Why?
|
| Contraceptives, Oral | 1 | 1993 | 555 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1995 | 2668 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2004 | 13268 | 0.010 |
Why?
|
| Peptides | 1 | 2000 | 4434 | 0.010 |
Why?
|
| Postmenopause | 1 | 1995 | 2420 | 0.000 |
Why?
|
| Ambulatory Care | 1 | 1997 | 2773 | 0.000 |
Why?
|
| Recurrence | 1 | 1996 | 8269 | 0.000 |
Why?
|
| Inflammation | 1 | 2003 | 10082 | 0.000 |
Why?
|
| Neoplasm Staging | 1 | 1998 | 11192 | 0.000 |
Why?
|
| Models, Biological | 1 | 1996 | 9895 | 0.000 |
Why?
|